© 2022 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
Experts in cardiovascular medicine share strategies for the practical management of obstructive hypertrophic cardiomyopathy.
May 6th 2022
Martin S. Maron, MD, discusses the incidence and prevalence of hypertrophic cardiomyopathy and age of disease expression.
Steve R. Ommen, MD, leads a review of common mutations seen in hypertrophic cardiomyopathy and the role of biomarkers and genetic testing in HCM.
Organizations Call on FDA To Help Address Recurrent C Difficile Burdens
Wonder Drake, MD: Understanding the Progression Patterns of Sarcoidosis
Presence of Residual Subretinal Fluid May Be Linked to Better BCVA in nAMD Treatment